Skip to main content

Advertisement

Log in

Association of Wnt2 and sFRP4 Expression in the Third Trimester Placenta in Women With Severe Preeclampsia

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Background

The Wnt signaling pathway is a conserved pathway and plays a crucial role in regulating trophoblast functions. Abnormal expression of the Wnt pathway may result in the dysfunction of the trophoblast that can contribute to the pathogenesis of preeclampsia (PE). However, published data regarding the association between Wnt pathway and PE in human pregnancy is rare.

Objective

The aims of this study were to investigate the expression pattern of Wnt2 and secreted frizzled-related protein 4 (sFRP4) in the third trimester human placenta and to evaluate the relationship between changes in placental Wnt2 and sFRP4 expression and severe PE.

Methods

The expression of Wnt2 and sFRP4 in normal and severe PE placentas was examined using immunohistochemistry (IHC), real-time polymerase chain reaction, and Western blot.

Results

Compared to the controls, the relative expression of Wnt2 messenger RNA was remarkably downregulated in the PE placentas, while there was no significant difference in sFRP4 between the 2 groups. The IHC indicated that Wnt2 and sFRP4 were expressed predominantly in the villous syncytiotrophoblast and the extravillous trophoblast, whereas Wnt2 in the control group showed higher staining intensity than in the PE group, and sFRP4 in the PE group had a higher staining intensity than in the control group. Furthermore, the results of the Western blots were consistent with the IHC.

Conclusions

The Wnt signaling pathway was detected in human third trimester placentas, and the decreased placental expression of Wnt2 and increased placental expression of sFRP4 may be associated with the pathogenesis of severe PE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beaufils M. Pregnancy hypertension. Nephrol Ther. 2010;6(3):200–214.

    Article  CAS  Google Scholar 

  2. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009;24(3):147–158.

    Google Scholar 

  3. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2(2):72–83.

    Article  CAS  Google Scholar 

  4. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech. 2012;5(1):9–18.

    Article  CAS  Google Scholar 

  5. Sonderegger S, Pollheimer J, Knofler M. Wnt signalling in implantation, decidualisation and placental differentiation– review. Placenta. 2010;31(10):839–847.

    Article  CAS  Google Scholar 

  6. Fitzgerald JS, Germeyer A, Huppertz B, et al. Governing the invasive trophoblast: current aspects on intra- and extracellular regulation. Am J Reprod Immunol. 2010;63(6):492–505.

    Article  CAS  Google Scholar 

  7. Sonderegger S, Haslinger P, Sabri A, et al. Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/ AKT activation. Endocrinology. 2010;151(1):211–220.

    Article  CAS  Google Scholar 

  8. Sonderegger S, Husslein H, Leisser C, Knofler M. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta. 2007;28(suppl A):S97–S102.

    Article  Google Scholar 

  9. Miller JR. The Wnts. Genome Biol. 2002;3(1):REVIEWS3001.

    Google Scholar 

  10. Turashvili G, Bouchal J, Burkadze G, Kolar Z. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology. 2006;73(5):213–223.

    Article  CAS  Google Scholar 

  11. Katoh M. WNT2 and human gastrointestinal cancer (review). Int J Mol Med. 2003;12(5):811–816.

    CAS  PubMed  Google Scholar 

  12. Fu L, Zhang C, Zhang LY, et al. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/beta-catenin signalling pathway. Gut. 2011;60(12):1635–1643.

    Article  CAS  Google Scholar 

  13. Mazieres J, You L, He B, et al. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer. 2005; 117(2):326–332.

    Article  CAS  Google Scholar 

  14. Park JK, Song JH, He TC, Nam SW, Lee JY, Park WS. Overexpression of Wnt-2 in colorectal cancers. Neoplasma. 2009;56(2):119–123.

    Article  CAS  Google Scholar 

  15. Wang GX, Zhang ZY, Pu PY, et al. Expression of core components of Wnt2 signaling pathway in gliomas. Zhonghua Bing Li Xue Za Zhi. 2009;38(7):481–482.

    PubMed  Google Scholar 

  16. Watanabe O, Imamura H, Shimizu T, et al. Expression of twist and wnt inhuman breast cancer.Anticancer Res. 2004;24(6):3851–3856.

    CAS  PubMed  Google Scholar 

  17. Kuster K, Koschel A, Rohwer N, Fischer A, Wiedenmann B, Anders M. Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1alpha. Cancer Gene Ther. 2010;17(2):141–146.

    Article  CAS  Google Scholar 

  18. You L, He B, Xu Z, et al. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res. 2004;64(15):5385–5389.

    Article  CAS  Google Scholar 

  19. Gong YD, Dong MS, Lee SB, Kim N, Bae MS, Kang NS. A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/beta-catenin pathway inhibitors in non-small-cell lung cancer cell lines. Bioorg Med Chem. 2011;19(18):5639–5647.

    Article  CAS  Google Scholar 

  20. Klein D, Demory A, Peyre F, et al. Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1. Angiogenesis. 2009; 12(3):251–265.

    Article  CAS  Google Scholar 

  21. Monkley SJ, Delaney SJ, Pennisi DJ, Christiansen JH, Wainwright BJ. Targeted disruption of the Wnt2 gene results in placentation defects. Development. 1996;122(11):3343–3353.

    CAS  PubMed  Google Scholar 

  22. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA. Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem. 1999;274(23):16180–16187.

    Article  CAS  Google Scholar 

  23. Carmon KS, Loose DS. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res. 2008;6(6):1017–1028.

    Article  CAS  Google Scholar 

  24. Jacob F, Ukegjini K, Nixdorf S, et al. Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS One. 2012; 7(2):e31885.

    Article  CAS  Google Scholar 

  25. Castro M, Grau L, Puerta P, et al. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med. Sep 2010;8:86–96.

    Article  Google Scholar 

  26. Hewitt DP, Mark PJ, Dharmarajan AM, Waddell BJ. Placental expression of secreted frizzled related protein-4 in the rat and the impact of glucocorticoid-induced fetal and placental growth restriction. Biol Reprod. 2006;75(1):75–81.

    Article  CAS  Google Scholar 

  27. Muley A, Majumder S, Kolluru GK, et al. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol. 2010; 176(3):1505–1516.

    Article  CAS  Google Scholar 

  28. Tsai IH, Chen CP, Sun FJ, Wu CH, Yeh SL. Associations of the pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in Taiwanese women. Asia Pac J Clin Nutr. 2012;21(1):82–87.

    PubMed  Google Scholar 

  29. Marshall NE, Guild C, Cheng YW, Caughey AB, Halloran DR. Maternal superobesity and perinatal outcomes. Am J Obstet Gynecol. 2012;206(5):417 e411-e416.

    Article  Google Scholar 

  30. Smolich BD, McMahon JA, McMahon AP, Papkoff J. Wnt family proteins are secreted and associated with the cell surface. Mol Biol Cell. 1993;4(12):1267–1275.

    Article  CAS  Google Scholar 

  31. Kemp C, Willems E, Abdo S, Lambiv L, Leyns L. Expression of all Wnt genes and their secreted antagonists during mouse blastocyst and postimplantation development. Dev Dyn. 2005;233(3):1064–1075.

    Article  CAS  Google Scholar 

  32. White L, Suganthini G, Friis R, Dharmarajan A, Charles A. Expression of secreted frizzled-related protein 4 in the primate placenta. Reprod Biomed Online. 2009;18(1):104–110.

    Article  CAS  Google Scholar 

  33. Fujita M, Ogawa S, Fukuoka H, et al. Differential expression of secreted frizzled-related protein 4 in decidual cells during pregnancy. J Mol Endocrinol. 2002;28(3):213–223.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhan Zhang MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., Zhang, L., Zhang, L. et al. Association of Wnt2 and sFRP4 Expression in the Third Trimester Placenta in Women With Severe Preeclampsia. Reprod. Sci. 20, 981–989 (2013). https://doi.org/10.1177/1933719112472740

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719112472740

Keywords

Navigation